Merck's Gardasil 9 offers at least 6 years of cancer protection, data show

10th October 2017 Uncategorised 0

Merck’s Gardasil 9 has come to dominate the HPV vaccine market, and a new, large-scale, phase 3 study that shows its protection against cancer lasts six years will only serve to strengthen its case.

More: Merck's Gardasil 9 offers at least 6 years of cancer protection, data show
Source: fierce